A Study of LY4060874 in Healthy Participants

NCT06709820 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

121

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Participants

Interventions

DRUG: LY4060874
DRUG: LY4060874
DRUG: Placebo
DRUG: Placebo

Sponsor

Eli Lilly and Company